Correlation Between Denali Therapeutics and Kymera Therapeutics
Can any of the company-specific risk be diversified away by investing in both Denali Therapeutics and Kymera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Denali Therapeutics and Kymera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Denali Therapeutics and Kymera Therapeutics, you can compare the effects of market volatilities on Denali Therapeutics and Kymera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Denali Therapeutics with a short position of Kymera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Denali Therapeutics and Kymera Therapeutics.
Diversification Opportunities for Denali Therapeutics and Kymera Therapeutics
0.9 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Denali and Kymera is 0.9. Overlapping area represents the amount of risk that can be diversified away by holding Denali Therapeutics and Kymera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kymera Therapeutics and Denali Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Denali Therapeutics are associated (or correlated) with Kymera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kymera Therapeutics has no effect on the direction of Denali Therapeutics i.e., Denali Therapeutics and Kymera Therapeutics go up and down completely randomly.
Pair Corralation between Denali Therapeutics and Kymera Therapeutics
Given the investment horizon of 90 days Denali Therapeutics is expected to generate 1.14 times more return on investment than Kymera Therapeutics. However, Denali Therapeutics is 1.14 times more volatile than Kymera Therapeutics. It trades about 0.15 of its potential returns per unit of risk. Kymera Therapeutics is currently generating about 0.01 per unit of risk. If you would invest 2,084 in Denali Therapeutics on November 2, 2024 and sell it today you would earn a total of 274.00 from holding Denali Therapeutics or generate 13.15% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Denali Therapeutics vs. Kymera Therapeutics
Performance |
| Timeline |
| Denali Therapeutics |
| Kymera Therapeutics |
Denali Therapeutics and Kymera Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Denali Therapeutics and Kymera Therapeutics
The main advantage of trading using opposite Denali Therapeutics and Kymera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Denali Therapeutics position performs unexpectedly, Kymera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kymera Therapeutics will offset losses from the drop in Kymera Therapeutics' long position.| Denali Therapeutics vs. Stoke Therapeutics | Denali Therapeutics vs. Black Diamond Therapeutics | Denali Therapeutics vs. 4D Molecular Therapeutics | Denali Therapeutics vs. Ascendis Pharma AS |
| Kymera Therapeutics vs. Foghorn Therapeutics | Kymera Therapeutics vs. Shattuck Labs | Kymera Therapeutics vs. Monte Rosa Therapeutics | Kymera Therapeutics vs. Nurix Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |